Delivra Signs Exclusive Licensing Deal with ARA-Avanti Rx Analytics for Hemp Non-Psychoactive Cannabinoid, Terpene and Flavonoid ...
TORONTO, ON--(Marketwired - May 10, 2017) - Delivra Corp. (TSX VENTURE: DVA) ("Delivra" or the "Company") and ARA-Avanti Rx Analytics Inc. ("Avanti") announced today a strategic partnership to develop a unique suite of …